News | January 28, 2022
Lupin signs promotional agreement with Exeltis on SOLOSEC
SOLOSEC is designed to be easy to take and one oral dose contains a complete course of treatment
SOLOSEC is designed to be easy to take and one oral dose contains a complete course of treatment
Companies plan to commercialize breath-based detection of lung infection and transplant rejection
First participants enrolled in clinical trial received Omicron-based vaccine candidate as a two-dose primary series and as a booster dose
The country is sixth among the most affected countries by active cases
This agreement allows Natco to expand access to Covid-19 medicines in 105 countries in generic name
Yoga helps to build a strong immune system and daily breathing regime of 10-minute helps in the long run
Krivida Novus can detect the Omicron variant and its sub-lineages in 45 minutes
Prof Karikó's research was most notably used by Pfizer/BioNTech and Moderna to build COVID-19 mRNA vaccines
The drug is aimed at treating Covid-19 patients with Acute Respiratory Distress Syndrome (ARDS)
Their strong recommendation is based on moderate certainty evidence that it improves survival and reduces the need for ventilation
Subscribe To Our Newsletter & Stay Updated
